EP253: How to Use Health IT to Help Patients and Providers Collaborate, With George Mathew, Chief Medical Officer at DXC Technology
Relentless Health ValueDecember 12, 201930:1741.6 MB

EP253: How to Use Health IT to Help Patients and Providers Collaborate, With George Mathew, Chief Medical Officer at DXC Technology

Right now, I am in the middle of rereading The Innovator’s Dilemma—that seminal work by Clayton Christensen. I’m at the chapter right now where he talks about resources (human and otherwise), processes, and values. These three things are the trifecta that determines what any organization can manage to achieve—or not achieve, as the case may be with disruptive technologies.

Here’s where this is relevant to health IT. You can have the most dedicated team who has built out and proven a digital tool that meaningfully improves patient outcomes and that patients embrace. But if the organization surrounding that team does not have the processes and the values that support this team, the effort will, at best, be suboptimal.

In this health care podcast, I speak with George Mathew, MD, MBA, FACP, and Chief Medical Officer, Americas, over at DXC Technology. We talk about the why and the how of patient/provider collaborations when it comes to digital tools. We spend some time on the process prong of Clayton Christensen’s trifecta. From there, there’s news you can use, like what’s going on with the FDA pre-cert program. And then we also get into how digital tools are being inserted into clinical workflows to greater or lesser effect.

I can probably also claim that we freewheel our way through some resources and some values advice, but at a minimum, we touch on a number of adjacencies to the process of creating and deploying digital tools effectively, including the why of it all.

You can learn more at dxc.technology. 

George Mathew, MD, MBA, FACP, is the Chief Medical Officer for the North American health care organization for DXC Technology, the entity created by the merger between Hewlett Packard Enterprise Services and Computer Sciences Corporation (CSC). In this role, Dr. Mathew serves as the clinical expert and health care thought leader to our health care clients in the transforming health care marketplace in payer, provider, life sciences, and state and local Medicaid business.

His experience includes consulting, technology development, and business development work at GE; Goldman, Sachs and Co.; WebMD; Pfizer; and Aetna. Dr. Mathew brings a strong technology innovation focus to this role, having founded a health care technology start-up earlier in his career, and advises several health care IT start-ups.


02:27 What the FDA pre-cert program is.
03:46 The cost of drug tests and clinical trials.
04:41 Coming up with standards for evaluating digital therapeutics.
06:45 “The Hives”—the database where all data collected are reviewed.
08:00 The data collected and how they are evaluated.
08:33 The barriers to developing digital therapeutics.
11:43 The Innovator’s Dilemma by Clayton Christensen.
13:37 “Getting people to help construct the solution.”
15:25 Workflows and how digital therapeutics play into this.
17:22 “The technology has always been easy; the hard part is the workflow change.”
20:49 How the information appears within these apps.
22:43 The opportunities within digital therapeutics.
23:33 Cognitive load vs clicks.
24:30 How information gets back to patients—or doesn’t.
27:29 “Hospitals should become data companies, except … that they work on behalf of their patients.”
27:53 DXC Technology and where people can learn more about the work that they do.
29:21 “What is the real problem you’re trying to solve, and what’s the right process to solve that problem?”

care,digital,health,healthcare,marketing,tech,therapeutics,dxc technology,

Recent Episodes

EP468: Very Common Assumptions That Aren’t Actually True About Member Engagement and the Healthcare Industry, With Matt McQuide
March 20, 2025
468
34:3931.72 MB

EP468: Very Common Assumptions That Aren’t Actually True About Member Engagement and the Healthcare Industry, With Matt McQuide

This conversation today with Matt McQuide is such a follow-on to the episode from last week where I encapsulated a major theme from the past five or six episodes. I know I’m on a roll. The thing is, if an employer doesn’t take the initiative and steer members or help them navigate through our curre...

EP467: Connecting Sky-High ER Spend to Primary Care Access—Following the Dollar Through Carriers and Hospitals, With Stacey Richter
March 13, 2025
467
23:0921.19 MB

EP467: Connecting Sky-High ER Spend to Primary Care Access—Following the Dollar Through Carriers and Hospitals, With Stacey Richter

Here’s my new idea for an episode. Welcome to it. I want to talk about a major theme running through the last few episodes of Relentless Health Value. And this theme is, heads up, going to continue through a few upcoming shows as well. For a full transcript of this episode, click here . If you enjo...

EP466: What Is Rising Faster, Insurance Premiums or Hospital Prices? With Vivian Ho, PhD
March 06, 2025
466
36:1233.13 MB

EP466: What Is Rising Faster, Insurance Premiums or Hospital Prices? With Vivian Ho, PhD

This episode has three chapters. Each one answers a key question, and, bottom line, it all adds up to action steps directly and indirectly for many, including plan sponsors probably, community leaders, and also hospital boards of directors. Here’s the three chapters in sum. For a full transcript of...

EP465: The Not Super Effective Contracting Industry Norm, Where Jumbo Plans and Others Wind Up Paying $10,000 for $50 Drugs, With Chris Crawford
February 27, 2025
465
34:1531.34 MB

EP465: The Not Super Effective Contracting Industry Norm, Where Jumbo Plans and Others Wind Up Paying $10,000 for $50 Drugs, With Chris Crawford

First of all, everybody listening here has probably heard of the lawsuit in which J&J—and talking about J&J as a large employer here now, not as a drug company—but J&J is (or maybe was, there’s action afoot) being sued by a plan member because, here’s the short version, allegedly, the J...

EP464: ER Visits Now 6% of Total Plan Spend. Is It Upcoding or What? With Al Lewis
February 20, 2025
494
31:4028.99 MB

EP464: ER Visits Now 6% of Total Plan Spend. Is It Upcoding or What? With Al Lewis

Today, I am speaking with the one, the only Al Lewis, and we’re gonna talk about how 6% of a lot of plan sponsors’ total spend is now going to ER/ED (emergency room/emergency department) visits. That’s a lot of spend. For a full transcript of this episode, click here . If you enjoy this podcast, be...

EP463: Medicare Advantage Policies—Which Will Stay and Which Will Go Now? With Betsy Seals
February 13, 2025
463
35:1132.2 MB

EP463: Medicare Advantage Policies—Which Will Stay and Which Will Go Now? With Betsy Seals

Every Gen X’er listening to this is gonna be singing that Clash  song in your head for the rest of the day. So, let’s turn our attention to Medicare Advantage policy. And on the show today, I grill the one and only Betsy Seals to find out which policies she thinks are going to stay and which a...

Encore! EP384: How Shareholders Impact Carrier Behavior, Exactly and Specifically, With Wendell Potter
February 06, 202535:0132.05 MB

Encore! EP384: How Shareholders Impact Carrier Behavior, Exactly and Specifically, With Wendell Potter

I am drowning in all things Q1 right now. So, this week we’re going with an encore. But this is a great show to go back and reflect upon, as it’s about carriers and how shareholders impact the actions of said carriers. For a full transcript of this episode, click here . If you enjoy this podcast, b...

Listen and Follow

Sponsored by Aventria Health Group
©2025 BD Bridges LLC. All Rights Reserved.